Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States

The decision to treat advanced gastroesophageal cancers (GECs) with targeted therapy and immunotherapy is based on key biomarker expression (human epidermal growth factor receptor 2 (HER2), programmed cell death-ligand 1 (PD-L1), microsatellite instability (MSI), and/or mismatch repair (MMR)). Real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Rutika, Liepa, Astra M., Zheng, Shen, Chatterjee, Anindya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955769/
https://www.ncbi.nlm.nih.gov/pubmed/36826106
http://dx.doi.org/10.3390/curroncol30020145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955769/
https://www.ncbi.nlm.nih.gov/pubmed/36826106
http://dx.doi.org/10.3390/curroncol30020145

Ejemplares similares